Menopause and Heart Health: Palpitations, Rising Cardiovascular Risk, and What to Do
Ask most women what their biggest health risk is after menopause, and few will say their heart. Breast cancer feels more front-of-mind. But here’s a truth the data makes unmistakable: cardiovascular disease is the leading cause of death in women — and a woman’s cardiovascular risk rises meaningfully after menopause, as the hormonal protection she had for decades fades.
This isn’t meant to frighten — it’s meant to empower. Because midlife is precisely the window to get ahead of heart health, while there’s the most opportunity to change the trajectory. The same transition that raises the risk also offers the clearest moment to act on it.
At Refine by Tulsi, cardiovascular and metabolic health is part of the whole-body view we take in our physician-led Refine Her program. Here’s what changes at menopause, why, and how to protect your heart for the decades ahead. (This article is educational — your personal cardiovascular care should always be directed by your physician or cardiologist.)
Why Estrogen Protected Your Heart — and What Changes
Before menopause, women have a relative cardiovascular advantage over men of the same age, and estrogen is a major reason. Estrogen supports the health of blood vessels, helps maintain favorable cholesterol patterns, and contributes to a less inflammatory internal environment — all protective for the heart and arteries.
As estrogen declines through perimenopause and menopause, that protection gradually fades. Over the years that follow, women’s cardiovascular risk rises toward — and eventually can exceed — that of men. This shift is one of the most important and least-discussed aspects of the menopause transition.
The Statistic Worth Knowing
Heart disease is the number one cause of death in women — more than all cancers combined. Yet it remains underestimated by many women, who may not realize that the menopause transition is a key moment when cardiovascular risk begins to climb. Awareness is the first step to prevention.
What Actually Changes at Midlife
The rise in cardiovascular risk isn’t one single change — it’s several, often arriving together:
Cholesterol shifts
LDL (“bad”) cholesterol and other lipids often rise after menopause, while protective patterns may decline — changing the cardiovascular picture.
Blood pressure rises
Blood pressure tends to increase through and after the transition, adding cardiovascular strain.
Visceral fat increases
The shift to abdominal, visceral fat (“menopause belly“) is specifically linked to cardiometabolic risk.
Insulin resistance grows
Rising insulin resistance raises the risk of metabolic syndrome and type 2 diabetes — both major cardiovascular risk factors.
Inflammation rises
As estrogen’s anti-inflammatory effect fades, rising inflammation contributes to vascular and cardiovascular risk.
Vascular changes
Blood vessels can become less flexible, affecting how the cardiovascular system responds and adapts.
Notice how interconnected these are — visceral fat drives insulin resistance and inflammation, which affect blood pressure and lipids, which affect the vessels. This is why a piecemeal approach falls short, and why cardiovascular protection at midlife is really about addressing the whole metabolic picture.
Getting Ahead of It: What Helps
The empowering part: cardiovascular risk at midlife is substantially modifiable. The window around menopause is one of the best opportunities to change your long-term trajectory. A proactive approach works across several fronts — always in partnership with your physician and, where appropriate, your cardiologist.
Know Your Numbers
Comprehensive assessment is the foundation: blood pressure, a full lipid panel, blood sugar and insulin markers, inflammatory markers, and body composition. You can’t protect what you haven’t measured — and midlife is the time to establish a clear cardiovascular baseline.
Address the Metabolic Drivers
Because visceral fat, insulin resistance, and the metabolic shift are central to the risk, addressing them — through medical weight support, muscle preservation, and nutrition — is one of the most powerful cardiovascular protections. Notably, some GLP-1 medications have shown cardiovascular benefits in research beyond weight alone.
Consider the Hormonal Picture
The relationship between hormone therapy and cardiovascular health is nuanced and genuinely individual — timing, personal history, and risk factors all matter, which is the heart of the “window of opportunity” discussion. This is a decision to make carefully with a physician who evaluates your full picture, not a generic recommendation.
Calm Inflammation & Support Cells
Because inflammation contributes to cardiovascular risk, addressing it — through metabolic health, targeted support, and lifestyle — is part of heart protection. Cellular support like NAD+ fits a broader longevity approach.
The Lifestyle Foundation
Unchanged and essential: regular aerobic and resistance exercise, a heart-healthy diet, not smoking, limiting alcohol, managing stress, and quality sleep. These remain the single most powerful cardiovascular protections, and every medical strategy builds on them.
An Important Boundary
Cardiovascular health is serious medicine. This article is educational and doesn’t replace care from your physician or cardiologist. If you have symptoms like chest pain, shortness of breath, or palpitations — or known heart disease — seek appropriate medical care. A longevity-focused wellness program complements, but never replaces, proper cardiac evaluation and treatment.
Want to understand your cardiovascular and metabolic baseline at midlife? Book a consultation at refinebytulsi.com/book. We assess the metabolic picture and coordinate with your broader care to help you get ahead of heart health.
The Refine Her Approach to Midlife Heart Health
Our Refine Her program takes a whole-body, longevity-focused view precisely because the cardiovascular risk of midlife is so interconnected with metabolism, inflammation, and hormones. Led by Dr. Tulsi Kotecha and Dr. Laura Ruof, the program assesses the metabolic and inflammatory drivers of cardiovascular risk, supports healthy body composition and weight, and considers the hormonal picture — all within a coordinated plan, and in partnership with your other physicians. Rather than waiting for cardiovascular disease to appear, it’s built around getting ahead of it during the window when it matters most.
This proactive, preventive philosophy is the essence of treating menopause as a longevity turning point rather than a transition to endure.
Real Patient Experiences
My cholesterol and blood pressure crept up after menopause and I didn’t connect it to the transition. Dr. Ruof laid out the whole metabolic picture — the visceral fat, the insulin changes, the inflammation — and we built a plan that addressed all of it alongside my primary care. My numbers are heading in the right direction and I finally feel like I’m getting ahead of my heart health instead of waiting for a problem.
I had no idea heart disease was the biggest risk for women my age. Dr. Kotecha didn’t scare me — she empowered me. Understanding that midlife was my window to protect my heart changed how I think about this whole chapter. I’m treating my cardiovascular health as a priority now, not an afterthought.
Frequently Asked Questions
Are heart palpitations a symptom of menopause?
Yes — palpitations, a racing or fluttering heart, and new temperature sensitivity are common during perimenopause and menopause, linked to fluctuating estrogen and the body’s shifting autonomic balance. They’re usually not dangerous, but palpitations should never be assumed benign: new, frequent, or severe palpitations — especially with chest pain, shortness of breath, dizziness, or fainting — warrant prompt evaluation by a physician or cardiologist to rule out a cardiac cause.
Does menopause really increase heart disease risk?
Women’s cardiovascular risk rises through and after the menopause transition as estrogen’s protective effects fade — with changes in cholesterol, blood pressure, visceral fat, insulin resistance, and inflammation. Heart disease is the leading cause of death in women, making this one of the most important aspects of midlife health to address.
Does hormone therapy protect the heart?
The relationship is genuinely nuanced and individual — timing, personal history, and risk factors all matter, which is what the “window of opportunity” concept addresses. Hormone therapy is not prescribed as a heart treatment, and whether it’s appropriate for you is a careful decision to make with your physician based on your full picture.
Can losing weight reduce my cardiovascular risk?
Addressing visceral fat and the metabolic shift is one of the most powerful levers for cardiovascular risk at midlife. Some GLP-1 medications have also shown cardiovascular benefits in research beyond weight alone. We address the metabolic drivers as part of a coordinated plan, alongside your other care.
What should I get tested?
A comprehensive baseline: blood pressure, full lipid panel, blood sugar and insulin markers, inflammatory markers, and body composition. Knowing your numbers is the foundation of getting ahead of cardiovascular risk. We assess these and coordinate with your physician or cardiologist.
Does this replace seeing a cardiologist?
No. A longevity-focused wellness program complements but never replaces proper cardiac care. If you have heart disease or symptoms, your cardiologist directs your treatment. We focus on the metabolic, inflammatory, and lifestyle drivers of risk, in partnership with your medical team.
The Bottom Line
Cardiovascular disease is the leading cause of death in women, and the menopause transition is when risk begins to climb as estrogen’s heart protection fades — through shifts in cholesterol, blood pressure, visceral fat, insulin resistance, and inflammation. But midlife is also the best window to get ahead of it, because so much of that risk is modifiable.
At Refine by Tulsi, Refine Her takes a proactive, whole-body approach to the metabolic and inflammatory drivers of cardiovascular risk — in partnership with your physicians — so you can protect your heart for the decades ahead. Don’t wait for a problem. Get ahead of it.
Get Ahead of Your Heart Health
Book a consultation at our Lincoln Park or Logan Square location. We’ll assess your metabolic and cardiovascular picture and build a proactive plan through Refine Her — in partnership with your care team.
About Your Refine Her Physicians
Dr. Tulsi Kotecha, MD is the founder and medical director of Refine by Tulsi, with locations in Lincoln Park and Logan Square, Chicago. Dr. Laura Ruof leads the Refine Her longevity and hormone optimization programs, focusing on metabolic health and whole-body vitality. Together they address the metabolic and inflammatory drivers of midlife cardiovascular risk as part of coordinated, preventive women’s medicine.
This article is for educational purposes only and does not constitute medical advice. Cardiovascular health should be evaluated and managed by your physician or cardiologist. Hormone therapy, GLP-1 medications, and related treatments should be administered under the guidance of a qualified physician, and decisions about cardiovascular risk and hormone therapy must be individualized. If you experience symptoms such as chest pain, shortness of breath, or palpitations, seek medical care promptly. Individual results may vary.






